Teresa J. Vietti

Q: What Schools Are Affiliated With Teresa J. Vietti

Teresa J. Vietti is affiliated with the following schools: Rice University, Washington University in St. Louis, Baylor College of Medicine, New York University

Teresa J. Vietti's AcademicInfluence.com Rankings

Teresa J. Vietti

Philosophy

#10621

World Rank

#14569

Historical Rank

#1976

USA Rank

Logic

#7485

World Rank

#9261

Historical Rank

#1139

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Teresa J. Vietti Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Teresa J. Vietti was an American physician. She is best known for her pioneering work and research in pediatric cancer. Her research discovered the genetics of leukemia, new chemotherapy agents and tracked the effects of chemotherapy on childhood cancer survivors. Vietti also wrote about her research and was an editor of the Journal of Pediatric Hematology and a co-editor of Clinical Pediatric Oncology. According to Washington University in St. Louis, she was known as "the mother of pediatric cancer therapy."

(See a Problem?)

Teresa J. Vietti's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. (2003) (1127)
The intergroup rhabdomyosarcoma study‐I. A final report (1988) (807)
The intergroup rhabdomyosarcoma study‐II (1993) (677)
Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. (1990) (519)
Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II. (1990) (364)
Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. (2001) (281)
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. (2000) (273)
Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma (1989) (219)
Ewing's sarcoma metastatic at diagnosis results and comparisons of two intergroup Ewing's sarcoma studies (1990) (203)
Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission (1970) (198)
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. (2004) (180)
Combined effect of x radiation and 5-fluorouracil on survival of transplanted leukemic cells. (1971) (172)
Parenchymatous degeneration of the central nervous system in childhood leukemia (1974) (169)
Interval between symptom onset and diagnosis of pediatric solid tumors. (1991) (162)
Clinical Pediatric Oncology (1978) (160)
Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study. (1991) (152)
Phase I Trial and Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Topotecan Using a Five‐Day Course in Children with Refractory Solid Tumors: A Pediatric Oncology Group Study (1996) (132)
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group Study. (1996) (127)
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. (2007) (120)
Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study. (2001) (112)
Factors influencing survival in pediatric acute leukemia. The SWCCSG experience, 1958–1970 (1973) (108)
Pre-B cell leukemia responds poorly to treatment: a pediatric oncology group study. (1984) (106)
Intergroup Ewing's sarcoma study. Local control related to radiation dose, volume, and site of primary lesion in Ewing's sarcoma (1980) (102)
Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study. (1981) (101)
Clinical investigations in the treatment of meningeal leukemia: radiation therapy regimens vs. conventional intrathecal methotrexate. (1969) (100)
Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study. (1993) (87)
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—a report from the Children's Oncology Group (2007) (86)
A staging system for histiocytosis X: A southwest oncology group study (1981) (85)
Risk factors for Wilms tumor: Report from the national Wilms tumor study (1993) (82)
Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: a Pediatric Oncology Group review. (1986) (79)
Serum Lactate Dehydrogenase in Childhood Neuroblastoma A Pediatric Oncology Group Recursive Partitioning Study (1992) (72)
The role of radiation therapy in the management of non-metastatic Ewing's sarcoma of bone. Report of the Intergroup Ewing's Sarcoma Study. (1981) (68)
Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report. (1994) (68)
Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study. (1998) (68)
Therapy of histiocytosis X with vincristine, vinblastine, and cyclophosphamide. The Southwest Cancer Chemotherapy Study Group. (1972) (66)
Ewing's sarcoma of the vertebral column. (1979) (65)
Multidrug adjuvant chemotherapy for osteosarcoma: interim report of the Southwest Oncology Group Studies. (1978) (64)
Prolonged infusion of arabinosyl cytosine in childhood leukemia (1970) (61)
Quality of survival in histiocytosis X: a Southwest Oncology Group study. (1980) (60)
Primary Ewing's sarcoma of the ribs: A report from the intergroup Ewing's sarcoma study (1983) (60)
Radiotherapy and combination chemotherapy in advanced Ewing's sarcoma–Intergroup study (1981) (59)
Multidrug chemotherapy in pulmonary treatment of osteosarcoma. (1976) (59)
Preservation of the bladder in patients with rhabdomyosarcoma. (1997) (58)
Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin. (1974) (55)
Natural history of histiocytosis X: a Pediatric Oncology Group Study. (1986) (51)
An Extrarenal Wilms' Tumor Arising from a Sacrococcygeal Teratoma (1974) (51)
THE RESPONSE OF ACUTE CHILDHOOD LEUKEMIA TO AN INITIAL AND A SECOND COURSE OF PREDNISONE. (1965) (50)
Ewing's sarcoma in bones of the hands and feet: a clinicopathologic study and review of the literature. (1985) (47)
6‐azauridine in combination chemotherapy of childhood acute myelocytic leukemia (1972) (47)
Clinical evaluation of cyclophosphamide. A new agent for the treatment of children with acute leukemia. (1962) (47)
Treatment of Wilms' tumor and factors affecting prognosis (1973) (46)
A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study. (1991) (46)
Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin. (1972) (46)
Synergistic antileukemic effect of 6-aminonicotinamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on L1210 cells in vitro and in vivo. (1982) (44)
Protracted intermittent schedule of topotecan in children with refractory acute leukemia: a pediatric oncology group study. (2002) (43)
Combination intrathecal therapy for meningeal leukemia: two versus three drugs (1977) (42)
Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group study. (1999) (41)
Superiority of conventional intrathecal methotrexate therapy with maintenance over intensive intrathecal methotrexate therapy, unmaintained, or radiotherapy (2000‐2500 rads tumor dose) in treatment for meningeal leukemia (1975) (40)
Bilateral Wilms' tumor. A review (1972) (40)
Remission maintenance therapy for meningeal leukemia: intrathecal methotrexate vs. intravenous bis-nitrosourea. (1971) (40)
Cyclophosphamide Dose Escalation in Combination with Vincristine and Actinomycin‐D (VAC) in Gross Residual Sarcoma: A Pilot Study Without Hematopoietic Growth Factor Support Evaluating Toxicity and Response (1995) (38)
The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate. (1975) (38)
Evaluation of chemotherapy in children with metastatic Ewing's sarcoma and osteogenic sarcoma. (1971) (37)
Multimodal therapy in metastatic Ewing's sarcoma: an Intergroup Study. (1981) (36)
Combination chemotherapy in histiocytosis X. (1977) (36)
Clinical study of daunomycin and prednisone for induction of remission in children with advanced leukemia. (1969) (35)
Ataxia telangiectasia with granulocytopenia. (1970) (35)
Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study. (1981) (34)
Kinetics of the lethal effect of actinomycin D on normal and leukemic cells. (1973) (34)
Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo. (1974) (33)
Stage IV‐S neuroblastoma. Results with definitive therapy (1984) (32)
Local control and survival related to radiation dose and volume and to chemotherapy in non-metastatic Ewing's sarcoma of pelvic bones. (1978) (32)
DESFERRIOXAMINE IN THE TREATMENT OF ACUTE TOXIC REACTION TO FERROUS GLUCONATE. (1963) (31)
Ovarian teratoma: Ultrastructure and neural component (1968) (30)
Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A pediatric oncology group study (1991) (30)
Chemotherapy of acute leukemia in childhood. Comparison of cyclophosphamide and mercaptopurine. (1966) (30)
Myeloid-antigen expression in childhood acute lymphoblastic leukemia. (1991) (29)
Observations on the prophylactic use of vitamin Kin the newborn infant. (1960) (29)
Combined etoposide and 5-azacitidine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group Study. (1987) (29)
An analysis of neuroblastoma at a single institution (1984) (29)
Cellular quantitation of in vivo effects of 1-beta-D-arabinofuranosylcytosine on leukemia L1210. (1977) (28)
Tumors of the sympathetic nervous system in children. An appraisal of treatment and results. (1967) (27)
Clinical study of daunomycin (NSC‐82151) in children with acute leukemia (1968) (25)
Vincristine sulfate in the treatment of neuroblastoma in children. (1966) (25)
Cyclophosphamide treatment for metastatic soft tissue sarcoma. Intermittent large doses in the treatment of children. (1967) (25)
Chemotherapy of childhood medulloblastoma. (1976) (25)
Embryonal rhabdomyosarcoma of the head and neck in children (1973) (25)
Adjuvant chemotherapy in nonmetastatic osteosarcoma: a Southwest Oncology Group Study. (1980) (25)
Fluorescence of the erythrocytes in lead poisoning in children: an aid to rapid diagnosis. (1959) (23)
Combined treatment modalities of rhabdomyosarcoma in children (1977) (23)
Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study. (1995) (22)
Phase 1 Study of Paclitaxel Administered Twice Weekly to Children With Refractory Solid Tumors: A Pediatric Oncology Group Study (2003) (22)
Immunoglobulin patterns in childhood leukemia (1970) (22)
Sarcomas of bone in childhood: pathologic aspects. (1981) (20)
Combination intrathecal therapy for meningeal leukemia: two versus three drugs. (1977) (19)
Chemotherapeutic trials in patients with metastatic retinoblastoma. (1968) (19)
Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study. (1998) (18)
Phototherapy for jaundice. (1970) (18)
High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study. (1991) (17)
Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. (1990) (17)
Infectious mononucleosis, lymphoblastic leukemia, and the E. B. virus (1969) (15)
Old man river. The flow of pediatric oncology. (2001) (15)
Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells. (1978) (15)
Trisomy 21 in bone marrow cells of a patient with a prolonged preleukemic phase. (1980) (15)
Cantharidin poisoning from ingestion of a "Blister Beetle". (1967) (14)
Evaluation of dosage schedules of mitomycin C (NSC-26980) in children. (1971) (13)
Treatment of malignant sympathetic tumors in children: clinicopathological correlation. (1968) (13)
Kinetics of both leukemic and normal cell population reduction following 5-azacytidine. (1975) (12)
Evaluation of dose and schedule of L-asparaginase in multidrug therapy of childhood leukemia. (1976) (12)
Congenital hypogammaglobulinemia preceding Hodgkin's disease: a case report and review of the literature. (1970) (12)
Complications and total care of a child with acute leukemia (1975) (11)
Properdin factor B and acute lymphocytic leukemia (ALL) (1982) (11)
Phase I Trial of Rebeccamycin Analog (NSC #655649) in Children With Refractory Solid Tumors: A Pediatric Oncology Group Study (2003) (11)
Long-term results in the treatment of acute nonlymphocytic leukemia: a Pediatric Oncology Group Study. (1989) (10)
Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice. (1981) (10)
Cutaneous angiosarcoma as a second malignant neoplasm after peripheral primitive neuroectodermal tumor. (1992) (10)
Hereditary spherocytosis associated with sickle trait and choliithiasis. (1963) (10)
The changing management of Wilms' tumor over a 30‐year period 1949‐1978 (1985) (10)
Preliminary report: clinical trials with cyclophosphamide in children with acute leukemia. (1960) (10)
CLINICAL MANIFESTATIONS OF PRIMAQUINE-SENSITIVE ANEMIA. (1965) (10)
Remission induction in acute myelogenous leukemia using cytosine arabinoside synchronization: a Southwest Oncology Group Study. (1978) (10)
Vitamin K1 Prophylaxis in the Newborn (1961) (10)
A Phase I study of acivicin in refractory pediatric solid tumors (2004) (9)
Response of childhood histiocytosis X to procarbazine (NSC-77213). (1974) (8)
Cytotoxic effect of 5-fluorouracil plus cyclophosphamide against transplantable leukemias. (1981) (7)
Combination of vincristine and prednisone in therapy of acute leukemia in children. (1968) (7)
Interval and sequence dependent lethal effects of cis diammine dichloroplatinum (Cis-Pt) in combination with other agents (1979) (7)
Combined effect of cytosine arabinoside and thiopurines. (1976) (7)
Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study. (1980) (7)
Biological characterization of a prolonged antileukemic effect of 5-azacytidine. (1977) (7)
Phase I trial of indicine-N-oxide in children with leukemia and solid tumors: a Pediatric Oncology Group study (2008) (7)
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation (2001) (7)
Prognostic features of Ewing's sarcoma on radionuclide bone scan after initial treatment. (1994) (7)
Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies. (1979) (7)
Comparison of cytotoxic action of iphosphamide and cyclophosphamide. (1981) (6)
Novantrone for childhood malignant solid tumors (2004) (6)
The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML). (1992) (6)
Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A Pediatric Oncology Group study. (1991) (5)
Influence of continuous infusion of cytosine arabinoside on sequencing with daunorubicin in L1210 leukemia. (1978) (5)
Immunoglobulin pattern in childhood leukemia. (1970) (5)
Wilms' tumour in father and son. (1973) (5)
Statistics of conducting clinical trials for children with brain tumors (1985) (4)
Overview of conference on sarcomas of soft tissue and bone in childhood. (1979) (4)
Actinomycin D: kinetics of its lethal action on a transplantable leukemia. (1971) (4)
Clinical trials with cyclophosphamide in the treatment of acute leukemia in children. (1962) (4)
Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors (1992) (4)
Antineoplastic chemotherapy. (1977) (4)
Adjuvant Chemotherapy in the Treatment of Osteosarcoma: Results of the Multi-Institutional Osteosarcoma Study (1988) (4)
Enhancement of the lethal effects of adriamycin (adria) by combining with other agents. Abstr. (1975) (4)
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia (2004) (3)
Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice. (1980) (3)
Conceptual basis for use of chemotherapeutic agents and their pharmacology. (1976) (3)
Uracil mustard (NSC-34462) therapy for children with metastatic neuroblastoma. (1968) (3)
Cyclophosphamide cystitis. (1969) (3)
Effect of dose fractionation of daunorubicin on survival of leukemic cells. (1980) (3)
L-phenylalanine mustard (NSC-8806) administration in osteogenic sarcoma: an evaluation of dosage schedules. (1971) (3)
URACIL MUSTARY THERAPY IN METASTATIC WILMS'S TUMOR. (1964) (2)
Clinical trials with 1-acetyl-2-picolinoylhydrazine (NSC-68626) in children. (1975) (2)
Combination chemotherapy study for remission maintenance in ALL: an evaluation of vincristine, cyclophosphamide and vincristine, cyclophosphamide, and BCNU: a Southwest Oncology Group Phase II Study. (1981) (2)
Wilms' tumor in father and son. (1974) (2)
Evaluation of uracil mustard in children with Hodgkin's disease, lymphosarcoma, and soft tissue sarcoma. (1972) (2)
The importance of Phase I/II trials in pediatric oncology (2004) (2)
Radiation therapy in the multimodality management of Ewing's Sarcoma of bone A report of the intergroup EWING'S SARCOMA study group (1979) (1)
Schedule dependence of the synergistic lethal effects of cyclophosphamide (CY) and 1,3 bis(2 chloroethyl) 1 nitrosurea (BCNU) (1974) (1)
Local control and survival related to radiation dose and volume and to chemotherapy in Ewing's sarcoma in the pelvis (1977) (1)
Uracil mustard (NSC-34462) therapy in uncommon malignant neoplasms in children. (1968) (1)
Comparison of clonogenic and increase in lifespan assays (1980) (1)
Delayed cytotoxicity of 5 azacytidine (AzaC) (1975) (1)
Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C) (1987) (1)
Survival of L1210 leukemia cells and normal hematopoietic stem cells following in vivo administration of cyclocytidine (2004) (1)
Early Intensive Chemotherapy for Children with Acute Myelogenous Leukemia: The Pediatric Oncology Group Experience (1981–1991) (1994) (1)
Survival of hematopoietic and leukemic colony-forming cells in vivo after administration of mitomycin C or porfiromycin. (1973) (1)
Prognostic value of radiographic characteristics in Ewing's sarcoma (1978) (0)
Hypersplenism in a child with acute lymphatic leukemia. (1973) (0)
CLINICAL STUDY OF DAUNOMYCIN (NSC-82 15 1) IN CHILDREN WITH ACUTE LEUKEMIA WRITING COMMITTEE: * CHARLENE P. HOLTON, bin, CHAIRMAN (1968) (0)
Vitamin K-1 prophylaxis in the newborn. (1961) (0)
The Evolution of Therapy for Acute Lymphatic Leukemia in Children (1985) (0)
Iron deficiency anemia of infancy. Management, with clinical evaluation of imferon. (1959) (0)
Malignant sympathetic tumors in children. (1969) (0)
Cyclophosphamide P lus T opotecan i n C hildren W ith Recurrent o r R efractory S olid T umors: A P ediatric Oncology G roup P hase I I S tudy (2001) (0)
Neuroblastoma: a review of the experience at washington university (1981) (0)
Comparison of cytotoxicity of single dose and infusion of alkylating agents. (1985) (0)
Book Review:Pediatric Hematology, Second Edition (1999) (0)
TIME AND CAUSE OF DEATH FROM HISTIOCYTOSIS (1977) (0)
Baker's antifol in children with late-stage acute lymphocytic leukemia. (1978) (0)
Kinetics of dihydroazacytidine (DHAza) cytotoxicity differ from 5-azacytidine (Aza) (1979) (0)
Acknowledgment to reviewers (1987) (0)
Azacytidine (aza) combination with vincristine (vcr), arabino- sylcytosine (ara) or adriamycin (adr). Abstr. (1977) (0)
PROCEEDINGS, XI INTERNATIONAL CANCER CONGRESS, FLORENCE 1974 (1975) (0)
Effect of actinomycin d (ad) on transplanted leukemic cells (tlc) and normal hematopoietic stem cells (nhsc). Abstr. (1971) (0)
A comparison of cyclophosphamide therapy with 6-mercaptopurine therapy in children with untreated acute leukemia (1965) (0)
Pediatric chemotherapy. (1975) (0)
Radiotherapy and combination chemotherapy in metastatic Ewing's Sarcoma — intergroup study (1979) (0)
Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside. (1981) (0)
Delayed cytotoxicity of 5-azacytidine (azac). Abstr. (1975) (0)
Massive feto-maternal transfusion : report of a case. (2012) (0)
From 5-azacytidine (aza). Abstr. (1979) (0)
Long term follow-up of wilms' tumor survivors (1981) (0)
Observations on the toxicity of diethanolamine. (1962) (0)
group study Pre-B cell leukemia responds poorly to treatment: a pediatric oncology (2011) (0)
The role of radiotherapy in the intergroup ewing's sarcoma study (1977) (0)

This paper list is powered by the following services:

Other Resources About Teresa J. Vietti

en.wikipedia.org

What Schools Are Affiliated With Teresa J. Vietti?

Teresa J. Vietti is affiliated with the following schools: